Panacur Equine Guard Horse Wormer is for the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines.
This product is effective for the treatment and control of encysted mucosal 3rd and 4th stage small strongyle larvae and is also effective against encysted inhibited 3rd stage small strongyle larvae in the mucosa. It is also effective in controlling other immature and mature roundworms including large redworm (Strongylus edentatus and Strongylus vulgaris) and migrating large redworm, Ascarids (Parascaris equorum), Oxyuris and Strongyloides spp. and benzimidazole-susceptible adult and immature small strongyles. Fenbendazole also has an ovicidal effect on nematode eggs.
Use of a scale or weigh tape is recommended to ensure accurate dosing. Panacur Equine Guard is a 10% w/v suspension of Fenbendazole as a ready to administer oral anthelmintic for horses. 1 ml of this product contains 100 mg active ingredient Fenbendazole.
No dietary control is required before or after treatment. For the treatment and control of migrating and tissue larval stages of large strongyles, encysted mucosal 3rd and 4th stage small strongyle larvae and encysted inhibited 3rd stage small strongyle larvae in the mucosa, administer 5ml of the product per 65 kg bodyweight daily for 5 days (= 7.5 mg fenbendazole/kg bodyweight daily for 5 days). The product can be easily administered by mixing with grain or concentrate feed. The full daily dosage must be given as one administration. Pregnant mares and foals may also be safely treated with fenbendazole at therapeutic dosage levels. Assess bodyweight as accurately as possible before calculating the dosage. The use of a ‘weigh band’ is recommended.
Treatment of encysted inhibited and encysted mucosal dwelling larvae should be performed in the autumn (ideally late October/November) and again in the Spring (ideally in February). However, for horses that fail to maintain condition or bought-in horses with unknown worming history, the treatment can be given at any time of the year. Treatment with this product should form part of an integrated worming plan. Fenbendazole belongs to the benzimidazole (1-BZ) class of anthelmintics. Studies have indicated that inhibited 3rd stage small strongyle larvae represent 50% of the total larval population in the horse.
Contra-indications, warnings, etc:
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any). Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used. Resistance to fenbendazole has been reported in cyathostomes in horses. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics. Intensive use or misuse of anthelmintics can give rise to resistance. To reduce this risk, dosing programmes should be discussed with your veterinary surgeon.
Operator warnings:
Direct contact with the skin should be kept to a minimum. Wear suitable protective clothing including impermeable rubber gloves. Wash hands after use.
Withdrawal periods:
Not to be used in horses intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation. For animal treatment only. Keep out of the sight and reach of children.
Pharmaceutical precautions:
Protect from freezing. Shake container before use. Mix the medicated feed thoroughly prior to administration, for example by rolling the drum or barrel. Liquid feed containing Panacur Equine Guard will remain stable for up to 3 months. Keep container in outer carton.
Disposal advice:
Dangerous to fish and aquatic life. Do not contaminate ponds, waterways or ditches with product or used container. Dispose of empty packaging and any remaining product in the household refuse.